Free Trial

R1 RCM (RCM) Competitors

R1 RCM logo
$14.31 0.00 (0.00%)
(As of 11/19/2024 ET)

RCM vs. TMX, MANT, EVH, FC, LH, DGX, DVA, CHE, CRVL, and AMED

Should you be buying R1 RCM stock or one of its competitors? The main competitors of R1 RCM include Terminix Global (TMX), ManTech International (MANT), Evolent Health (EVH), Franklin Covey (FC), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), and Amedisys (AMED).

R1 RCM vs.

R1 RCM (NASDAQ:RCM) and Terminix Global (NYSE:TMX) are both mid-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

61.1% of R1 RCM shares are held by institutional investors. Comparatively, 92.2% of Terminix Global shares are held by institutional investors. 36.8% of R1 RCM shares are held by company insiders. Comparatively, 2.3% of Terminix Global shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

R1 RCM received 222 more outperform votes than Terminix Global when rated by MarketBeat users. However, 61.32% of users gave Terminix Global an outperform vote while only 57.17% of users gave R1 RCM an outperform vote.

CompanyUnderperformOutperform
R1 RCMOutperform Votes
287
57.17%
Underperform Votes
215
42.83%
Terminix GlobalOutperform Votes
65
61.32%
Underperform Votes
41
38.68%

In the previous week, R1 RCM had 10 more articles in the media than Terminix Global. MarketBeat recorded 10 mentions for R1 RCM and 0 mentions for Terminix Global. R1 RCM's average media sentiment score of 0.99 beat Terminix Global's score of 0.00 indicating that R1 RCM is being referred to more favorably in the media.

Company Overall Sentiment
R1 RCM Positive
Terminix Global Neutral

R1 RCM has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, Terminix Global has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.

R1 RCM currently has a consensus target price of $15.41, suggesting a potential upside of 7.71%. Given R1 RCM's stronger consensus rating and higher probable upside, equities research analysts plainly believe R1 RCM is more favorable than Terminix Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
R1 RCM
0 Sell rating(s)
13 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.28
Terminix Global
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Terminix Global has a net margin of 3.15% compared to R1 RCM's net margin of -2.48%. Terminix Global's return on equity of 4.95% beat R1 RCM's return on equity.

Company Net Margins Return on Equity Return on Assets
R1 RCM-2.48% -2.18% -1.10%
Terminix Global 3.15%4.95%2.67%

Terminix Global has lower revenue, but higher earnings than R1 RCM. R1 RCM is trading at a lower price-to-earnings ratio than Terminix Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
R1 RCM$2.46B2.45$3.30M-$0.15-95.40
Terminix Global$2.05B2.25$125M$0.5371.45

Summary

R1 RCM beats Terminix Global on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCM vs. The Competition

MetricR1 RCMManagement services IndustryBusiness SectorNASDAQ Exchange
Market Cap$6.04B$7.81B$6.87B$8.81B
Dividend YieldN/A3.27%2.90%4.06%
P/E Ratio-95.3914.9846.2217.82
Price / Sales2.452.15204.2274.56
Price / Cash20.8715.6824.0532.53
Price / Book2.1812.135.044.68
Net Income$3.30M$156.61M$121.42M$226.08M
7 Day Performance0.07%-3.72%0.18%-1.04%
1 Month Performance0.49%-8.26%8.35%1.04%
1 Year Performance36.68%-5.34%30.36%26.28%

R1 RCM Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RCM
R1 RCM
3.181 of 5 stars
$14.31
flat
$15.41
+7.7%
N/A$6.04B$2.25B-95.3930,000News Coverage
TMX
Terminix Global
0.3916 of 5 stars
$37.87
flat
N/AN/A$4.61B$2.05B71.4511,700
MANT
ManTech International
N/A$95.98
flat
N/A+0.0%$3.93B$2.55B32.329,800
EVH
Evolent Health
3.5821 of 5 stars
$11.43
+1.1%
$28.90
+152.8%
-61.3%$1.33B$2.46B-12.414,700Analyst Forecast
FC
Franklin Covey
4.1727 of 5 stars
$35.94
+1.8%
$63.33
+76.2%
-10.0%$473.69M$287.23M20.281,084Short Interest ↓
Positive News
LH
Laboratory Co. of America
4.7778 of 5 stars
$238.00
+0.1%
$255.92
+7.5%
+12.7%$19.91B$12.71B46.0167,000Positive News
DGX
Quest Diagnostics
4.9045 of 5 stars
$161.98
+0.4%
$164.58
+1.6%
+19.7%$18.08B$9.25B21.6948,000Analyst Downgrade
DVA
DaVita
4.2959 of 5 stars
$162.57
+0.7%
$161.80
-0.5%
+65.5%$13.33B$12.14B17.4170,000Positive News
CHE
Chemed
4.9019 of 5 stars
$558.70
+1.1%
$641.50
+14.8%
-4.5%$8.41B$2.26B27.9815,087Ex-Dividend
Positive News
CRVL
CorVel
1.4222 of 5 stars
$356.74
+0.4%
N/A+66.0%$6.11B$795.31M75.424,870Positive News
AMED
Amedisys
3.9441 of 5 stars
$90.05
+0.1%
$100.67
+11.8%
-4.1%$2.95B$2.24B35.7119,000

Related Companies and Tools


This page (NASDAQ:RCM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners